Under The Influence: Prediction Markets Are Harnessing Modern Joe Camels
Brant James, Ingame
In January 2018, a class-action lawsuit was filed against Enzymatic Therapy for allegedly deceptively advertising that Ultra Liver Cleanse is able to “Remove Toxins” and cleanse and rejuvenate the liver when, according to plaintiffs, the product cannot detoxify, cleanse, or rejuvenate the liver. Plaintiffs also claim that the company misleads consumers by communicating that the product has “drug-like effects” when it is not an FDA approved drug. (Jocelyn et al v. Enzymatic Therapy, LLC, Case No. 18-cv-564, E.D.N.Y.)
Brant James, Ingame
Company becomes the latest to leave the industry.
The FTC’s Negative Option Rule do-over – and what’s at stake.
Be wary of questionable and deceptive claims in origin stories.
Mounting lawsuits accuse Meta of breaking privacy promises.